Berapakah harga Novo Nordisk A/S (NOVO-B)

Harga Novo Nordisk A/S (NOVO-B) adalah $47.55

Apakah topi pasaran Novo Nordisk A/S (NOVO-B)

Cap pasaran Novo Nordisk A/S (NOVO-B) adalah $211.25B

Novo Nordisk A/S (NOVO-B) Saham Dalam Edaran

Novo Nordisk A/S operates as a global healthcare enterprise, dedicated to the innovation, development, production, and commercialization of pharmaceutical solutions. Its business is primarily divided into two key segments: Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity Care segment offers a comprehensive portfolio of treatments for diabetes (including insulins, GLP-1 analogues, oral antidiabetic agents, and related delivery systems), obesity management, glucagon, medical needles, and other chronic conditions. The Rare Disease segment provides specialized medications for haemophilia, various blood disorders, endocrine imbalances, growth hormone deficiencies, and hormone replacement therapy. Additionally, the company engages in strategic alliances, including a partnership with Gilead Sciences, Inc., and conducts research focused on identifying cell-specific carriers for nucleic acid-based therapies. Established in 1923, Novo Nordisk A/S is headquartered in Bagsvaerd, Denmark.

Tahun	Saham Terbitan	Ubah
Tidak cukup data untuk tarikh yang disediakan.

Tahun

Saham Terbitan

Ubah

Tidak cukup data untuk tarikh yang disediakan.

Syarikat	Saham Terbitan	Perbezaan	Negara
Eli Lilly and Company LLY.US	892.40M	-79.92%	US
Johnson & Johnson JNJ.US	2.44B	-45.09%	US
AbbVie Inc. ABBV.US	1.77B	-60.15%	US
Roche Holding AG RO.SW	796.00M	-82.09%	CH
Merck & Co., Inc. MRK.US	0.00	-100.00%	US

Syarikat

Saham Terbitan

Perbezaan

Negara